Officer and Director Roger Susi Files Intent to Sell $9.87M in IRMD Stock, Continuing Recent Sales Pattern
IRMD has more than doubled off its 52-week low of $47.478.
Summary
Roger E. Susi, an Officer, Director, and 10% stockholder, has filed a Form 144 indicating intent to sell 100,000 shares of IRADIMED CORP common stock, valued at approximately $9.87 million. This follows a series of sales totaling $3.92 million over the past three months.
Key Events · Ownership and Investor Activity · IRMD
-
Intent to Sell Significant Stake
Roger E. Susi, an Officer, Director, and 10% stockholder, filed a Form 144 to sell 100,000 shares of common stock, valued at approximately $9.87 million.
-
Continuation of Recent Selling Trend
This proposed sale follows previous dispositions by the same insider, totaling 40,000 shares for $3.92 million over the past three months, indicating a sustained pattern of selling.
-
Key Insider Disposition
The filer's multiple roles as an Officer, Director, and 10% owner make this planned sale a notable event for investor sentiment, especially coming shortly after the company reported strong financial results.
Analysis · IRMD · Industrial Applications And Services
This Form 144 filing signals a significant planned disposition of shares by a key insider, Roger E. Susi, who holds multiple important roles as an Officer, Director, and 10% stockholder. The proposed sale of nearly $10 million in stock represents a notable portion of the company's market capitalization and suggests a continued trend of insider selling, as evidenced by the $3.92 million in sales over the last three months. While the company recently reported strong financial results, this consistent insider selling could be interpreted by investors as a lack of conviction or a move to diversify holdings, potentially creating an overhang on the stock.
How filings like this one have moved
In the 30 days to Sep 17, 2026, 40.7% of the 383 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.55%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IRMD was trading at $98.72 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $47.48 to $107.90. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.